| Inhaled Loxapine as a Rapid Treatment for Agitation in Patients with Personality Disorder: A Prospective Study on the Effects of Time | Clinical Psychopharmacology and Neuroscience | 2022 |
| Quality of Life And Disability of Patients With Bipolar Disorder According To Treatment Response | Socrates Journal of Interdisciplinary Social Researches | 2022 |
| Adverse childhood experiences and psychopathology in patients with OCD | Psychiatrie Pro Praxi | 2022 |
| Protocol for Rhapsody: a longitudinal observational study examining the feasibility of speech phenotyping for remote assessment of neurodegenerative and psychiatric disorders | BMJ Open | 2022 |
| Lived experiences of children and adolescents with obsessive–compulsive disorder: interpretative phenomenological analysis | Child and Adolescent Psychiatry and Mental Health | 2022 |
| Evidence-based Shared-Decision-Making Assistant (SDM-assistant) for choosing antipsychotics: protocol of a cluster-randomized trial in hospitalized patients with schizophrenia | BMC Psychiatry | 2022 |
| Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study | Frontiers in Neurology | 2022 |
| The impact of medication reviews by general practitioners on psychotropic drug use and behavioral and psychological symptoms in home-dwelling people with dementia: results from the multicomponent cluster randomized controlled LIVE@Home.Path trial | BMC Medicine | 2022 |
| Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors. | Journal of Child and Adolescent Psychopharmacology | 2022 |
| A Preliminary Evaluation of a Brief Behavioral Parent Training for Challenging Behavior in Autism Spectrum Disorder. | Journal of Autism and Developmental Disorders | 2022 |
| Development of the Clinical Gestalt Assessment: a visual clinical global impression scale for Proteus syndrome. | Orphanet Journal of Rare Diseases | 2022 |
| Low-Dose Ziprasidone in Combination with Sertraline for First-Episode Drug-Naïve Patients with Schizophrenia: a Randomized Controlled Trial. | Neurotherapeutics | 2022 |
| Progressive changes in descriptive discourse in First Episode Schizophrenia: a longitudinal computational semantics study | NPJ Schizophrenia | 2022 |
| Common measures or common metrics? A plea to harmonize measurement results. | Clinical Psychology and Psychotherapy | 2022 |
| Initial evaluation of a therapist-supported online cognitive therapy self-help for patients with taboo obsessions. | British Journal of Clinical Psychology | 2022 |
| Comparing retinal changes measured by optical coherence tomography in patients with schizophrenia and their siblings with healthy controls: Are retinal findings potential endophenotype candidates? | Asian Journal of Psychiatry | 2022 |
| Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study. | Current Medical Research and Opinion | 2022 |
| Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication Study. | Journal of Child and Adolescent Psychopharmacology | 2022 |
| Association between retinal vascular measures and brain white matter lesions in schizophrenia. | Asian Journal of Psychiatry | 2022 |
| A Chinese adaptation of six items, self-report Hamilton Depression Scale: Factor structure and psychometric properties. | Asian Journal of Psychiatry | 2022 |
| A Phase III Study of Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents Aged Between 7 and 17 Years with Autism Spectrum Disorder (SIGN 1 Trial): Participant Baseline Characteristics. | Child Psychiatry and Human Development | 2022 |
| A Multicenter Study on the Impact of Gender, Age, and Dual Diagnosis on Substance Consumption and Mental Health Status in Outpatients Treated for Substance Use Disorders During COVID-19 Lockdown. | Journal of Dual Diagnosis | 2022 |
| Serotonin reuptake inhibitor-cognitive behavioural therapy-second generation antipsychotic combination for severe treatment-resistant obsessive-compulsive disorder. A prospective observational study. | International Journal of Psychiatry in Clinical Practice | 2022 |
| Efficacy and Safety of Duloxetine in Children and Adolescents with Major Depressive Disorder in Japan: A Randomized Double-Blind Placebo-Controlled Clinical Trial Followed by an Open-Label Long-Term Extension Trial. | Journal of Child and Adolescent Psychopharmacology | 2022 |
| Protocol for a randomised controlled feasibility study examining the efficacy of brief cognitive therapy for the treatment of panic disorder in adolescents (PANDA). | Pilot and Feasibility Studies | 2022 |
